Significantly higher prevalence rate of asthma and bipolar disorder co-morbidity: A meta-analysis and review under PRISMA guidelines

Medicine (United States)

Volumn 95, Issue 13, 2016, Pages e3217-

  Wu, Ming Kung ^a,b   Wang, Hung Yu ^c   Chen, Yen Wen ^c   Lin, Pao Yen ^a,b   Wu, Ching Kuan ^d   Tseng, Ping Tao ^c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c Tsyr Huey Mental Hospital   (Taiwan)

^d E DA HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; BIPOLAR DISORDER; HUMAN; META ANALYSIS; PREVALENCE;

ASTHMA; BIPOLAR DISORDER; HUMANS; PREVALENCE;

EID: 84962735795     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003217     Document Type: Article

References (37)

1. Fernandes AG, Souza-Machado C, Coelho RC, et al. Risk factors for death in patients with severe asthma. J Bras Pneumol. 2014;40:364-372.
2. Vreeland B. Bridging the gap between mental and physical health: a multidisciplinary approach. J Clin Psychiatry. 2007;68(Suppl 4):26-33.
3. Deshpande DA, Dileepan M, Walseth TF, et al. MicroRNA regulation of airway inflammation and airway smooth muscle function: relevance to asthma. Drug Dev Res. 2015;76:286-295.
4. Dunican EM, Fahy JV. The Role of type 2 inflammation in the pathogenesis of asthma exacerbations. Ann Am Thorac Soc. 2015;12(Suppl 2):S144-S149.
5. Goldstein BI, Lotrich F, Axelson DA, et al. Inflammatory markers among adolescents and young adults with bipolar spectrum disorders. J Clin Psychiatry. 2015;76:1556-1563.
6. Su KP, Leu SJ, Yang YY, et al. Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission. J Affect Disord. 2002;71:205-209.
7. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-stage bipolar disorder. Int J Neuropsychopharma-col. 2009;12:447-458.
8. Brietzke E, Stertz L, Fernandes BS, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009;116:214-217.
9. Kim YK, Suh IB, Kim H, et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry. 2002;7:1107-1114.
10. Lin TC, Lee CT, Lai TJ, et al. Association of asthma and bipolar disorder: a nationwide population-based study in Taiwan. J Affect Disord. 2014;168:30-36.
11. Jerrell JM, McIntyre RS, Tripathi A, et al. A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. J Clin Psychiatry. 2010;71:1518-1525.
12. Mitchell PB, Johnston AK, Frankland A, et al. Bipolar disorder in a national survey using the World Mental Health Version of the Composite International Diagnostic Interview: the impact of differing diagnostic algorithms. Acta Psychiatr Scand. 2013;127:381-393.
13. Jerrell JM, McIntyre RS, Tripathi A, et al. Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder. Hum Psychopharma-col. 2011;26:451-459.
14. McIntyre RS, Konarski JZ, Soczynska JK, et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv. 2006;57: 1140-1144.
15. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64:53-59.
16. Schoepf D, Heun R. Bipolar disorder and comorbidity: increased prevalence and increased relevance of comorbidity for hospital-based mortality during a 12.5-year observation period in general hospital admissions. J Affect Disord. 2014;169:170-178.
17. Castilla-Puentes R, Secin R, Grau A, et al. A multicenter study of bipolar disorder among emergency department patients in Latin-American countries. Int J Psychiatry Med. 2011;42:49-67.
18. Chen MH, Su TP, Chen YS, et al. Higher risk of developing major depression and bipolar disorder in later life among adolescents with asthma: a nationwide prospective study. J Psychiatr Res. 2014;49:25-30.
19. Chen MH, Su TP, Chen YS, et al. Higher risk of mood disorders among adolescents with ADHD and asthma: a nationwide prospective study. J Affect Disord. 2014;156:232-235.
20. Alonso J, de Jonge P, Lim CC, et al. Association between mental disorders and subsequent adult onset asthma. J Psychiatr Res. 2014;59:179-188.
21. Brown ES, Suppes T, Khan DA, et al. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharma-col. 2002;22:55-61.
22. Tseng PT, Chen YW, Yeh PY, et al. Bone mineral density in schizophrenia: an update of current meta-analysis and literature review under guideline of PRISMA. Medicine (Baltimore). 2015;94:e1967.
23. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
24. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-e34.
25. Perugi G, Quaranta G, Belletti S, et al. General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases. J Affect Disord. 2015;170:95-103.
26. Davydow DS, Ribe AR, Pedersen HS, et al. Serious mental illness and risk for hospitalizations and rehospitalizations for ambulatory care-sensitive conditions in Denmark: a nationwide population-based cohort study. Med Care. 2016;54:90-97.
27. Li F, Xie X, Li S, et al. Interleukin-6 gene-174G/C polymorphism and bronchial asthma risk: a meta-analysis. Int J Clin Exp Med. 2015;8:12601-12608.
28. Daneshmandi S, Pourfathollah AA, Pourpak Z, et al. Cytokine gene polymorphism and asthma susceptibility, progress and control level. Mol Biol Rep. 2012;39:1845-1853.
29. Patakas D, Argiropoulou V, Louridas G, et al. Beta-blockers in bronchial asthma: effect of propranolol and pindolol on large and small airways. Thorax. 1983;38:108-112.
30. Brown ES, Khan DA, Nejtek VA. The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol. 1999;83 (6 Pt 1):495-503 quiz-4.
31. D'Amato G, Holgate ST, Pawankar R, et al. Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization. World Allergy Organ J. 2015;8:25.
32. von Bulow A, Kriegbaum M, Backer V, et al. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2:759-767.
33. Kuhlen JL Jr, Wahlquist AE, Nietert PJ, et al. Identification of asthma phenotypes in a tertiary care medical center. Am J Med Sci. 2014;348:480-485.
34. Davoodi P, Mahesh PA, Holla AD, et al. Serum levels of interleukin-13 and interferon-gamma from adult patients with asthma in Mysore. Cytokine. 2012;60:431-437.
35. Smart JM, Horak E, Kemp AS, et al. Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-gamma responses. J Allergy Clin Immunol. 2002;110:450-456.
36. Leonard C, Tormey V, Burke C, et al. Allergen-induced cytokine production in atopic disease and its relationship to disease severity. Am J Respir Cell Mol Biol. 1997;17:368-375.
37. Guloksuz S, Cetin EA, Cetin T, et al. Cytokine levels in euthymic bipolar patients. J Affect Disord. 2010;126:458-462.